- Demographic and clinical characteristics of patients with human parainfluenza virus type 3.
Variables | n (%) |
---|---|
Gender, male | 11 (50.0) |
Gestational age (weeks) | |
Preterm (<37 weeks) | 11 (50.0) |
Full term (>37 weeks) | 11 (50.0) |
Birth weight categories | |
751-1000 gr | 3 (13.6) |
1001-1500 gr | 5 (22.8) |
1500-2500 gr | 4 (18.2) |
>2500 gr | 9 (40.9) |
Age groups at time of HPIV-3 infection | |
less than one month | 1 (4.5) |
1-6 months | 6 (27.0) |
6-12 months | 4 (18.0) |
>12 months | 11 (50.0) |
Underlining medical condition | |
Patient with one or more underlining diseases | 18 (81.8) |
Neurologic disease | 9 (41.0) |
Cardiac disease | 2 (9.0) |
Preterm babies with CLD | 4 (18.2) |
Gastrointestinal disease | 2 (9.0) |
Other genetic syndromes | 5 (22.8) |
Main symptoms | |
Fever and cough with or without increased secretions | 10 (45.5) |
Cough with or without runny nose | 7 (31.8) |
Desaturation with or without cough or fever | 3 (13.7) |
Feed intolerance + cough or fever | 2 (9.0) |
Clinical presentation | |
LRTI | 18 (81.8) |
URTI | 4 (18.2) |
Oxygen therapy support | |
Yes with invasive ventilation (intubation/tracheostomy) | 4 (18.2) |
Yes with non-invasive ventilation (CPAP, HFNC, NC) | 12 (54.5) |
Room air | 6 (27.3) |
Duration of illness, mean (median [range]) | 17.5 days (17 days [8-39]) |
7-10 days | 4 (18.0) |
11-17 days | 7 (31.0) |
>17 days | 11 (50.0) |
Outcomes | |
Death | 1 (4.5) |
Well recovery | 21 (95.0) |
Variables are presented as numbers and percentages (%).
HPIV-3: human parainfluenza viruse type 3, CLD: chronic lung disease, LRTI: lower respiratory tract infection,
URTI: upper respiratory tract infection,
CPAP: continuous positive airway pressure,
HFNC: high flow nasal cannula, NC: nasal cannula